Welcome to article directory Asbestos Lawyers Site. Here You can find interesting and useful information on most popular themes.

There are 591 published articles and 1 registered authors in our article directory.

Recent Articles

Actos Bladder Cancer Lawsuits Notice

Actos Bladder Cancer Lawsuits : The incidence of bladder cancer has risen over the past 20 years. Currently, around 54 500 new cases of bladder cancer are diagnosed in the USA each year, and 15 000 cases in the UK. Bladder cancer is the fourth most common cancer in men in the USA and the tenth most common in women. It is one of the most frequent causes of cancer death, accounting for about 10 000 deaths annually in the USA and 5000 in the UK.

More information on Actos Bladder Cancer Lawsuits

The incidence of bladder cancer varies among different patient groups. For example, there is a 3:1 male-to-female ratio, though the prevalence among women appears to be rising.

The incidence is higher in elderly populations, with a median age at presentation of 60-65 years. No evidence exists for a familial or inherited pattern among any patient group, although occasional family clusters have been recorded. In black people the incidence is lower than in white people; in Asian races it appears to be intermediate. The lifetime risk of developing bladder cancer is:

  • 2.8% for white men
  • 0.9% for black men
  • 1.0% for white women
  • 0.6% for black women.

Information from other sources on Actos Bladder Cancer Lawsuits

Five-year survival for both black and white people during the period 1986-92 (60% and 82%, respectively) was significantly better than the equivalent rates for 1974-76 (47% and 74%, respectively; p < 0.05). It is not really known why there are substantial ethnic differences in incidence and prognosis, although putative factors include differences in diet and nutritional status, differences in gene expression (especially of enzymes that may metabolize carcinogens) and differential access to healthcare.

Our use of the term or terms Actos Bladder Cancer Lawsuits is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on (keyword) visit our site often.

Actos Bladder Cancer Lawsuits

Posted in Asbestos Lawyers Site | Tagged , |

Multaq Lawsuit Breaking News

Multaq Lawsuit : Chronic Hepatitis B and Long-term Liver Cancer Risk

People with chronic hepatitis B are at increased risk for developing liver cancer. The exact risk is unknown, but in some studies, people with chronic hepatitis B were two hundred times more likely to develop liver cancer compared with people without this disease. Cancer usually occurs in those who have developed cirrhosis. However, cancer can also occur in chronic HBV carriers without cir­rhosis. In fact, in some parts of the world where hepatitis B is endemic, such as in Africa, up to 30 percent of people with chronic hepatitis B develop liver can­cer without underlying cirrhosis.

Prom the time a person becomes infected with HBV, liver cancer generally takes about twenty to thirty years to develop. Thus, people who were infected at birth can develop liver cancer as early as the age of twenty. It appears that infec­tion with both HBV and HCV or infection with both HBV and HDV, drinking ex­cessive alcohol, and having a family history of HCC can increase the likelihood that a person will develop liver cancer. It has been noted that men appear to have an increased risk ot developing HCC compared to women. Whether this is due to hormonal differences is unclear. See chapter 19 for more information on HBV and liver cancer.

More information on Multaq Lawsuit

THE HEPATITIS DELTA VIRUS (HDV)

Hepatitis D is inflammation of the liver due to a virus called the hepatitis delta virus (HDV). HDV is a virus that can live only in people with hepatitis B. Ap­proximately 70,000 people in the United States are infected with HDV. Although HDV only accounts for a small percentage of cases of chronic viral hepatitis, it tends to be particularly severe and to have significant long-term consequences. In fact, chronic hepatitis D causes more than one thousand deaths each year in the United States. In the 1970s, hepatitis delta virus infection was endemic through­out Southern Europe. However, by the 1990s the incidence of HDV infection had significantly decreased. In fact, one study done in Italy estimated that the num­ber of cases of HDV within that country decreased by 1.5 percent each year from 1987 to 1997. And, it is anticipated that this trend will continue. Currently, new HDV infections are rare.

Information from other sources on Multaq Lawsuit

HDV infection may be silent or may cause the same kind of fatigue and other symptoms associated with other forms of hepatitis. However, up to 20 percent of hepatitis D patients develop fulminant hepatitis, a particularly serious condition that requires hospitalization. See chapter 7 for a discussion on fulminant hepatitis.

HDV is transmitted through the same blood, sexual, and perinatal routes as HBV, which were discussed on page 92. There are two ways in which a person infected with HBV may become infected with HDV: coinfection and superinfection. When HBV and HDV are acquired at the same time, it is known as coinfection. In 90 to 95 percent of cases, such people will be able to completely eliminate both viruses from their bodies. This means that only approximately 5 to 10 percent of coinfected individuals go on to develop chronic hepatitis B and D. HDV can also be acquired by someone who already has chronic hepatitis B. This is known as superinfection. In contrast to people infected with both viruses simultaneously, approximately 70 to 95 percent of people who become infected in this two-step fashion progress to chronic hepatitis D.

Our use of the term or terms Multaq Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawsuit visit our site often.

http://www.seedol.com

Posted in Asbestos Lawyers Site | Tagged , |

Actos Bladder Cancer Top News

Actos Bladder Cancer : You probably have already figured out that cystectomy is a surgical procedure performed under anesthesia in a hospital setting. Depending on what kind of bladder reconstruction you have, you may stay in the hospital anywhere from 5 to 14 days. The descriptions included here of medical procedures and treat­ments are of a general nature; your own experience may differ from what is discussed here. With cystectomy, an incision is made through the abdominal wall, so you can expect some mild discomfort at the incision site. The inci­sion will be covered, and you probably won’t be able to shower or get the incision wet for about a week to 10 days. You may have a drain from the incision, a flexible tube with a hollow bulb on the end that you will remove, empty, flush out, and reattach as needed. Your doc­tor will remove the drain (it’s painless) and any stitches or staples in a follow-up visit 10 days or so after your surgery.

Some possible complications include infection, bleeding, blood clots, or intestinal obstruction. You may experience some difficulties with your urinary diversion system. You’ll be asked to wait for a few weeks after surgery before you drive, and your doctors are likely to want you to refrain for several weeks from doing anything that strains the abdominal area, such as pushing and pulling a vacuum cleaner or lifting heavy objects or engaging in any other activity that might damage the scar or even pull the scar tissue apart, thereby risking the formation of a hernia. A her­nia occurs when your surgical scar pulls apart under the skin and allows a part of the underlying bowel to poke forward, creating a noticeable lump. It can interfere with the functioning of your bowel and therefore needs to be fixed, either with an external truss or sup­port, or possibly through another surgical operation.

It’s smarter just to avoid the risk in the first place by not stressing the scar soon after surgery. This is the time to take it easy and when possible allow friends or family to pamper you by helping with chores and housework. Just don’t get too used to having someone bring you the morning newspaper and a cup of coffeel Generally it’s a good idea to talk about this with your doctor and find out what you can and cannot safely do.There are some negative consequences of cystectomy that you should discuss thoroughly with your medical team. As mentioned above, there may be changes in urinary function. These will depend largely on the type of surgery and on whether an artificial bladder has been created. Sometimes while the abdominal tissues are healing after surgery there will be a period of irregular bowel function, during which you will unexpectedly have to deal with diarrhea or constipation.

More information on Actos Bladder Cancer

Occasionally there will be some swelling in one or both legs, due either to fluid retention or the formation of scar tissue around the lymph vessels that drain the legs. Often there will be the presence of an asymptomatic, low-grade chronic urinary tract infection that will be identified upon routine testing. This occurs because of the changed pattern of emptying the new bladder. Usually it causes no problems and doesn’t require active treatment with antibiotics. Other issues also arise. Worries about possible changes in sexual function are common, and very normal. Sexual function often does change after cystectomy That doesn’t mean you can’t have an active, playful, pleasurable sex life with your partner. It does mean that you’ll probably explore innovative strategies as you seek comfortable ways to experience fulfillment.

Men experience more extreme changes in sexual function after surgeiy than women do. Around half the men who undergo cystec­tomy experience nerve damage that leaves them impotent afterwards, a serious lifestyle change that is not only physical but emotional, requiring much thoughtful discussion between you, your partner, and your medical team both before surgery and after. If you are able to have an erection after surgery, you won’t be able to ejaculate, because ’without a prostate, your body is no longer able to produce semen. You’ll find that the physical sensation of orgasm is different from what you are accustomed to. It’s not unpleasant; just different. In general, the younger you are at the time of surgery, the more likely you will be to have erections or to regain over time the capability of having them. There are surgical procedures, such as penile inserts, that can help make sexual activity possible.

For women, a cystectomy includes the removal of the uterus and part of the vaginal wall. What does that mean for you? Well, for one thing, your vagina may be narrower as a result of the surgery. Usually it’s possible to continue to have intercourse, although sometimes there can be some pain involved. Be sure to talk to your doctor if you do experience pain as there are methods of reducing this.

Information from other sources on Actos Bladder Cancer

Most women diagnosed with bladder cancer already have experienced menopause. (Typically, women who receive diagnoses of bladder cancer are older.) For younger women, that may not be the case. The removal of the uterus and pos­sibly of other female organs near the Most women diagnosed bladder brings an abrupt end to the child- with bladder cancer bearing years. It may also set off typical already have experienced menopausal symptoms such as hot flash- menopause. (Typically, es or mood swings if the ovaries have women who receive been removed at surgery (removal of diagnoses of bladder ovaries is unusual). If you find yourself cancer are older.) feeling depressed or blue or uncomfort­able from hot flashes, talk to your doctor. You don’t have to feel that way; there are options available for you to consider.

As is recommended for men, talking with your partner and your medical team about the physical and emotional changes that you may experience after a cystectomy is an important part of the process, one that deserves as much consideration as the more immediate decisions about which treatment options you want to pursue. Keep in mind that cystectomy is a life-preserving weapon against invasive cancer. That doesn’t mean you can’t or shouldn’t consider the possibility of impotence or altered sexual function with your partner, or the inability to carry a child. It does offer the hope that you can celebrate many more years of healthy, loving life with your friends and family. That’s an important thing to remember at a time when life may seem to be serving you big helpings of despair.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Asbestos Lawyers Site | Tagged , |

Actos Side Effects Info

Actos Side Effects : More information on Actos Side Effects

After the initial shock of being given a new diagnosis of cancer, a flood of emotions follow with fear and anxiety being foremost. Questions fill your mind:

How serious is it?

Can 1 be cured?

Am I going to die?

Will I suffer?

What treatments are available?

Can 1 do anything to improve my odds?

What side effects will occur from the treatments?

Will I lose time from work?

Will my insurance cover the cost?

Will I be disfigured?

Will my spouse and family be supportive?

Do 1 have a good doctor?

Bladder cancer, or any serious potentially life threatening illness is generally alien to most individuals. Suddenly, lives are changed and a new reality must be dealt with. Becoming a “patient” or worse “a cancer patient” is not only threatening, but a dreaded proposition. Cancer patients are not happy with the loss of autonomy, the invasion of privacy, the discomfort inflicted upon them and the demands on their time and quality of life. As a patient, being thrust into this altered identity, it is essential to seek out the information you need. Having a fundamental base of knowledge is a must when facing the issues and treatment decisions which lie ahead. In the following pages, together we will explore bladder cancer, a disease which is totally foreign to most of us until the diagnosis is made. I have chosen to present the information in a question and answer format, written in a conversational tone, as if I were having an extended consultation with one of my patients. The questions are typical of what individuals have asked over the years. 1 have covered the key issues and decisions the individual with bladder cancer may face. The answers are to the point and cover the essentials required to make an informed decision for most individuals. For others, a more detailed resource may be required. For helpful sources of additional information see the Appendix.

Each individual’s situation is unique. Decisions on treatment may be modified based on the patient’s preferences and values and altered by other considerations such as age and coexisting conditions. By becoming an individual knowledgeable of bladder cancer, you will be prepared to fully partner with your physician for your best possible outcome. To your companions and family members, this book will serve to answer the many questions and doubts that may arise. Having your loved ones informed and supportive is a big plus for the individual facing this new challenge.

The book is written in a logical sequence starting with finding a qualified urologist to the basics on bladder cancer, its assessment and treatment. At the end of the book, you will find chapters on complementary medicine, advance care planning, and hospice care. The book can be read in sequence or each chapter can serve as a resource covering the basics of the topic. It is my hope this book will help clarify the many issues and options individuals must face with bladder cancer. For family members, significant others and concerned friends, this resource should help improve your understanding and thus your ability to assist your loved one.

 

Information from other sources on Actos Side Effects

Understanding bladder cancer is a tremendous first step that will assist you in your treatment. Having a qualified urologist administer the actual treatments and care for you is essential for the best possible outcome. In the following chapter, we will explore what you need to know to assure you have the right urologist.

BESIDES LEARNING ABOUT MY DISEASE, WHAT IS MY MOST IMPORTANT FIRST STEP?

Make sure you have an excellent urologist supervising your care. A urologist is a surgical specialist trained to care for conditions involving the male and female urinary tracts and the male reproductive system. The bladder is part of the urinary system, and a urologist is trained to care for problems involving it, including cancer.

IS IT IMPORTANT TO HAVE A BOARD CERTIFIED UROLOGIST?

A urologist board certified by The American Board of Urology has gone through an accredited urology training program (generally a four year program), following two years of internship and residency in surgery after four years of medical school. The urologist must be in practice after training and provide a detailed list of surgeries, including complications, over a twelve month period. The doctor will then take a two day oral and written test covering a wide spectrum of urology. If he passes, he is certified for a period of ten years. At the end of the ten year period, he must recertify to maintain his board status. Recertification entails a three month surgical and procedure log and a written test as well as reference letters from those in a position to judge the practicing urologist’s work. Any malpractice or judgments are also reviewed. Although being board certified does not guarantee you have an excellent urologist, it demonstrates that he has the fund of knowledge to practice urology competently. Even though board certification is voluntary, in today’s competitive environment more and more hospitals and insurance plans are requiring their specialists to be certified.

HOW CAN I TELL IF MY UROLOGIST IS BOARD CERTIFIED?

The urologist has worked hard to obtain board certification. The certificate from The American Board of Urology is often displayed openly in his office. If you do not see it, you can simply ask him or you can call 1-866-275-2267 or use this web site: www.certified doctor.org

SHOULD I TRY TO FIND A UROLOGIST WHO HAS BEEN IN PRACTICE FOR YEARS OR A NEWLY TRAINED ONE?

Surgery is a skill which can only be mastered with experience. The saying “practice makes perfect” definitely pertains to surgery. Although a urology training program offers the new physician years of training, his surgical skills will continue to improve with further experience. However, each individual physician has his own innate skills. Some more quickly learn and are simply better at the technical craft of surgery than others. For the most part, urologists finishing an accredited urology program have the training and skill set required to care for patients with bladder cancer.

Experience also counts. As a physician practices the art of medicine, his depth of knowledge and ability to treat grows. Ask your physician how long he has been treating patients with bladder cancer. If you require major surgery ask how many he has performed and if his complication rate matches what is expected.

Physicians by and large do improve as they practice, and all physicians are required to show that they are continuing to learn by partaking in continuing medical education, a requirement to remain licensed. Most physicians are compulsive in their medical practice and care deeply in the care they deliver. They continually strive to improve.

Some physicians may become “burned out” over the years as they continue to face the pressures of a busy medical practice. Similarly, towards the end of a surgeon’s career, technical skills may slip due to aging. New urologists are trained in the latest techniques and are familiar with recent medical literature, but may lack practical experience. In the end, recommendations from others and reputation may be your best guide to finding a qualified physician.

WHAT QUALITIES SHOULD MY UROLOGIST HAVE?

Ideally, you should have a competent, technically skilled surgeon who is also approachable and compassionate. You should be able to freely ask questions pertaining to your disease and treatment. Your physician should answer your questions forthrightly. Although some patients prefer a surgeon who will take over all aspects of care with no questions asked, most prefer in depth explanations, especially when alternatives exist and risks are involved.

Your urologist must be an individual who takes your concerns, priorities and values seriously. Your urologist should be a good communicator. It is his responsibility to keep you fully informed of your progress, make you aware immediately if things are not going well, and educate you fully in treatment alternatives. Your specific values should be incorporated into the decision process if alternatives are available. Even if your urologist makes a recommendation and you choose an alternative course (unless you are putting yourself in extreme jeopardy), he should honor your choice and continue his care of you. Becoming an educated patient will make your decision making process easier. Granted, your physician should provide you with the basics, however having time to review and digest the material will allow you to fully understand and accept your treatment regimen, providing you with peace of mind.

Beware of the physician who bombards you with statistics and studies and leaves the decision making to you. After all, you are not a physician and don’t have the practical hands on experience he does. Your physician should provide the facts and the statistics, guide you through the information, and make treatment recommendations based on your preferences.

You may find yourself emotionally distraught and overwhelmed. Having a physician on your side is invaluable. You should be able to trust your physician. Complete honesty on the part of your doctor in his care of you is a must. From the doctor’s point of view, trust is also a necessity. Physicians have an extremely difficult time dealing with individuals who do not trust them. Without trust, the physician patient relationship is extremely hindered.

Lastly, your urologist should be compassionate. Having cancer is tough enough, you shouldn’t have to deal with a rude or arrogant physician. Your urologist should be supportive at all times. He should treat you as an individual and not just as “another cancer patient.” People with bladder cancer will require long term follow up and care. Having a compassionate individual to work with will make a tremendous difference

HOW DO I FIND A GOOD BOARD CERTIFIED UROLOGIST?

A good starting point is your primary care physician. He will generally have a number of specialists to whom he generally refers his urology patients. If the primary care physician has been working with these urologists, he should have an appreciation of their skills and temperament. However, this does not mean he is referring you necessarily to the best available urologist in your area. His choices may be limited by insurance or hospital networks. An excellent source of information would be nurses who work in the operating room, recovery room or on the surgical floor where the urologist does his surgery. Asking friends or other individuals who have had experience with the urologist can also prove useful. After a little digging, you can often quickly learn what type of reputation the urologist has in the community. Generally, if an established urologist has a “good reputation” this is an indication that he has pleased many individuals with his care.

SHOULD I CHECK TO SEE HOW MANY TIMES MY UROLOGIST HAS BEEN SUED?

Given the litigious society we live in, most physicians can face at least one malpractice lawsuit during their careers. In urology, two of the most common causes of litigation would be a surgical mishap leading to a complication, or failure to diagnose cancer in a timely fashion.

Medicine is based on science, but also is an “art.” Individuals do not walk into their physicians offices with a diagnosis and treatment plan always readily apparent. Even the best intentioned, thorough physician will make mistakes. Most of these errors do not result in harm. On occasion they do, and a law suit may follow. If a physician develops a good working relationship with a patient, these bad outcomes more often than not are acknowledged and accepted without legal entanglement. Competent, busy physicians may be dealing with a higher mix of complicated patients, leading to a higher number of potential suits. Physicians who have poor “bed side manner” may find themselves dealing with more suits. If a physician has an inordinate number of suits, “red flags” should go up, as competency may be an issue.

For those individuals who wish to check out the malpractice history of their physician, you may request an inquiry from the National Practitioners Data Bank at: 1-800-767-6732 or check the web site: www.npdb-hipdb.com

Our use of the term or terms Actos Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Side Effects visit our site often.

http://www.seedol.com

Posted in Asbestos Lawyers Site | Tagged , |

Actos and Bladder Cancer Bulletin

Actos and Bladder Cancer : BC is a disease of the environment and age . Populations are increasing in number, and they are growing old as well., . Since more people are living longer, more are at potential risk. Furthermore, the changing environments in developed and developing countries are causing more carcinogen concentration than can be associated to genesis of BC. Several carcinogens have been correlated to BC carcinogenesis.However, it has been proposed that other environmental factors could affect the incidence on urothelial tumors. In fact, as for many other cancers, molecular researchers try to establish genetic alterations linked to carcinogenesis that could justify genetic predisposition.

Cancer is a major public health problem. At the end of the twentieth century, more than 930,000 people died of cancer every year in 15 member countries of the European Union (EU) (Coleman et al. 2003). Using population projections, if the age-specific death rates remain constant, the absolute number of cancer deaths in 2015 will increase to 140,500 (Boyle and Ferlay 2005). BC is a worldwide health problem. In 2006 in Europe, there were an estimated 104,400 incident cases of BC

 

More information on Actos and Bladder Cancer

diagnosed (82,800 in men and 21,600 in women) that represent a 6.6% of the total cancers in men and 2.1% in women. The estimated ratio by gender was 3.8:1, respectively. In men BC was the fourth most common cancer. Bladder cancer repre­sents a 4.1% of total deaths for cancer in men and 1.8% of total deaths in women (Ferlay et al. 2007). In the EU overall (27 countries), BC mortality rates were stable up to early 1990s, and declined, thereafter, by 16% in men and 12% in women, to reach values of 6 and 1.3/100,000, respectively, in the early years of the present decade. The only countries without declining mortality are Croatia and Poland in both sexes, Romania in men, and Denmark in women. This documented and quanti­fied reduction in BC mortality seems related to decrease in tobacco smoking, while its relationship with other risk factors remains controversial (Ferlay et al. 2008).In the United States, it is estimated that about 1.4 million new cases of cancer was diagnosed in 2008. Cancers of the prostate and breast are the most frequently diagnosed cancers in men and women, respectively, followed by lung and colorec­tal cancers in both men and in women. The fourth most common among men is the urinary BC. The 5-year relative survival rate for BC is 81% among whites and 65% among African-Americans (AAs) (taking the normal life expectancy into consider­ation) with an absolute difference of 16%. The survival rates for BC combined with certain site-specific cancer have improved significantly since the 1970s—being 74% during 1975-1977, 78% during 1984-1986, and 81% during 1996-2003.

 

Information from other sources on Actos and Bladder Cancer

Contrary to this data, the prevalence of BC among Native Americans/Alaskan Natives (NA/AN) is generally considered to be low. Despite this low incidence, NA/AN men and women seem to be at relatively greater risk of dying from BC, once it has been diagnosed (Watson and Sidor 2008).Tobacco use is a major preventable cause of death, and especially involved in BC carcinogenesis. The year 2004 marks the anniversary of the release of the first Surgeon General’s report on Tobacco and Health, which initiated a decline in per capita cigarette consumption in the United States (Jemal et al. 2008).

In Egypt, where BC has always been related to bilharziasis, a significance decline of the relative frequency of BC was observed from 27.63% in the old series to 11.7% in the recent series. Bilharzias association dropped from 82.4% to 55.3% and there was a significant increase of transitional cell carcinoma from 16% to 65%, while squamous cell carcinoma was less frequent—from 76% to 28%. Intimately related to this, there was an increase in the median age of patients from 47 to 60 years. The decline in the frequency of BC is related to a decline in bilhar- zias egg positivity in the specimen, and this suggests a better control of the endemic disease in rural population. This trend of less association with bilharzias has changed the clinical and pathological characteristics of BC diagnosed, with signifi­cant predominance of transitional cell carcinoma and an increase in the age of patients, a pattern more similar to that in western series (Gouda et al. 2007).

The incidence and mortality rates associated with BC vary by country, ethnicity, gender, and age. For indeterminate causes, the AAs have only half the risk of white European Americans, but overall, the survival seems to be worse among the primer group. The higher incidence in European Americans is limited to superficial tumors, both groups having a similar risk of invasive tumor (Kirkali et al. 2005).

 

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Asbestos Lawyers Site | Tagged , |

Actos Warning Information

Actos Warning: Occupational exposure has been considered the second most important risk factor for BC. Work related cases account for a 20%-25% of all BC cases in several series. The cause relation between chemical exposure and BC was reported more than a century ago among workers employed in the manufacture of dyestuffs containing aromatic amines (Pelucchi et al. 2006). Rehn reported in 1895 and 1896 a relationship between chemical exposure and BC among workers involved in the manufacture of coal tar derived magenta and auramine dyes, and 47 years later Hueper and Wolf demonstrated that 2-naphthylamines was the substance respon­sible for BC risk associated with chemical exposure (Johansson and Cohen 1997).The substances involved in chemical exposure had been benzene derivatives and arylamines (2-naphthylamine, 4-ABP, 4,4′-methylenedianiline and o-toluidine).

 

More information on Actos Warning

One study of municipal distribution of BC in Spain detected 34,281 BC deaths registered between 1989 and 1998. They could observe that determinate zones exhibited a higher risk than others, these being provinces of Cadiz, Seville, Huelva, Barcelona, and Almeria. The municipal mortality patterns suggested that the industrial and mining activity in the Provinces of Seville and Huelva could be associated with higher BC mortality in these provinces. The mortality pattern assessed in two different areas of the Province of Barcelona, which is only observable in women, might be related to the textile industry traditionally situated in these areas (Lopez-Abente et al. 2006).The trend to decrease BC due to occupational exposure was reported in a pooled analysis of 11 case-control studies on BC conducted in European countries between 1976 and 1996. This analysis included 3346 male cases and 6840 male controls. Thirty-one occupations showed increase risk for BC and these occupations were grouped as metal workers, textile workers, painters, miners, and transport opera­tors. Higher odd ratios were observed on those people with duration of employment more than 25 years. However, the author concluded that the ratio of BCs caused by occupational exposure was lower than those identified one year ago and that the exposure to occupational carcinogens had been reduced in the European Union.

 

Information from other sources on Actos Warning

This would likely be due to the improvement in working conditions and the reduction of exposure, particularly, to aromatic amines in work. Currently, employ­ments that relate more to BC risk are those in metal sector, machinists, transport operators, and miners (Kogevinas et al. 2003).In addition to the analysis on men, a pooled analysis of 11 case-control studies in BC conducted in Western Europe showed that the rates of BC due to occupa­tional exposure had been reduced in women, with only a 8% of BC in women attributable to occupational carcinogens (Mannetje et al. 1999). Although in devel­oped countries strict regulatory controls may have contributed to a decreased bur­den of exposure to bladder carcinogens in the workplace, the situation is less apparent in developing countries.As in BC, in general, occupational case is more frequent in men than in women, although, an increased risk among women has been documented in several studies, including those employed in the rubber industry and, more recently, in healthcare settings. In a case-control study conducted in Iowa, female teachers, domestic ser­vice employees, and workers in laundering and dry-cleaning business had elevated risk of BC. Other gender and racial differences had been documented in occupa­tional BC. In this way, in a recent mortality study in the United States, the mortality ratios for AA men and women and Latino males in various occupations were found to be increased compared with workers of the same gender and ethnic-racial group (Delclos and Lerner 2008).

 

Our use of the term or terms Actos Warning is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Warning visit our site often.

http://www.seedol.com

Posted in Asbestos Lawyers Site | Tagged , |

Actos and Bladder Cancer Resources

Actos and Bladder Cancer: NAVIGATING APPOINTMENTS

Calls initially made to a urology office or clinic are triaged by the scheduling staff who are trained to inquire about the current stage of your workup for your bladder cancer. It is most helpful to have a working knowledge of the tests and diagnoses you have already been given to best facilitate this process. The staff will schedule your initial appoint­ment and mail you all necessary instructions before your appointment. After your initial appointment, subsequent appointments may often be arranged by the individual team members’ staff over the phone. If at the initial ap­pointment it is determined you should have a consultation with another team member (e.g., medical oncologist or radiation oncologist), that appointment is often arranged for you on die day of your initial consultation with the uro- logic oncologist-—-before you leave the clinic if you choose. Therefore having your schedule available allows you to ef­ficiently make these arrangements without conflict.

 

More information on Actos and Bladder Cancer

FINANCIAL IMPLICATIONS OF TREATMENT/INSURANCE CLEARANCE

You probably never planned on getting diagnosed with bladder cancer. There is no convenient time to get this dis­ease, and the diagnosis alone can be difficult to manage. You will need to take time off from work and other duties for your surgery and possibly for other treatment after­ward. It is helpful then to “get your ducks in a row” early on. Finding out how much sick leave you have, short-term disability coverage, copayment information, prescription coverage, and other medical expense issues is helpful to plan for die changes this will have on your budget. Your insurance company may require referrals to be obtained to see certain specialists, to get tests done, to get surgery au­thorized, as well as to obtain other treatments. If you need help with these things, ask for a social worker to assist you. Financial coordinators are available in the clinic. They will work with you to help you navigate the financial aspect of this process.

Some treatments may be recommended that involve par­ticipation in a clinical trial. Usually, a research nurse will as­sist you with navigating the financial aspects of this line of therapy and can provide much of that information for you.

 

Information from other sources on Actos and Bladder Cancer

Financial support services are not well advertised. It re­quires you to take the initiative to ask about them rather than waiting for someone to tell you about them. Be asser­tive and do this for yourself That’s why these programs ex­ist. Money is the primary reason family members get into arguments. Avoid this up front by discussing the issue and planning a budget. Be proactive in asking to meet with the social worker to discuss what support services are available for you as well.

 

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

Actos and Bladder Cancer

Posted in Asbestos Lawyers Site | Tagged , |

Actos Lawyers Data

Actos Lawyers : The pathologist studies the prepared slides and makes a determination of the grade of cancer. There are a number of criterions that are used: degree of cellularity, nuclear crowding, loss of polarity and differentiation, nuclear pleomorphism, chromatin pattern and mitotic activity. In layman’s terms, the pathologist looks at the size, shape and relationship of the cancer cells. The nucleus is often abnormal since it contains damaged or mutated DNA. Cancer cells look different than normal cells. The greater the difference from normal, the higher the grade will be. These parameters are utilized to reduce the subjective nature of pathology. In the end, the pathologist assigns a grade. Since grading is actually a continuum, many pathologists find that by adding to the grading scale, they can more accurately grade what they are seeing.

The medical history of those with bladder cancer varies. For many patients, the first clue is blood in the urine, while in others, it may be an alteration in urination. Sometimes a tumor is found inadvertently on an X ray or ultrasound exam. In all cases, an initial assessment is implemented by the urologist. In this chapter, we will review the presenting findings of those with bladder cancer and how they are initially “worked up.”

For more information on Actos Lawyers follow us on our RSS Feeds.

A sign is a physical finding from an underlying disease or disorder which can be noted by the individual or the physician. A symptom is something the individual feels or experiences from a disease. A clinical sign is a physical finding, while a symptom is something the individual experiences. Approximately three quarters of individuals with bladder cancer initially present with blood in their urine. The blood may be visible to the naked eye (gross hematuria), or seen with a microscope only (microscopic hematuria). In the case of gross hematuria secondary to bladder cancer, it is often total (throughout the entire stream) and may be intermittent. Generally, there is no pain associated with it. I have seen many patients over the years who had gross hematuria months earlier who falsely assumed their condition was not serious since the bleeding stopped and there was no pain, only to come in later with recurrent bleeding, their tumors needlessly more advanced. When an individual experiences gross hematuria, a work up is a must! Gross hematuria at times can become quite severe to the point blood clots can restrict the flow of urine. What could have been an elective assessment then becomes a mad dash to the emergency room for catheterization (passing a tube into the bladder) and irrigation or an emergency procedure. Of course, there are other causes for gross hematuria, such as urinary infections, kidney stones or tumors in the kidney, all of which require assessment.

Information from other sources on Actos Lawyers

If a urine dipstick is positive for blood, it is recommended to check the urine under a microscope. The urine is first spun down to separate out the sediment and is then examined under the high power lens. If there are more than 3 red blood cells per high power field it is felt to be significant. If there are no other reasons for the presence of blood such as a urinary infection, the urine should be rechecked. If there is a persistent presence of significant microscopic hematuria, an assessment is recommended. When there is a large amount of microscopic hematuria, especially in older individuals with risk factors for bladder cancer, there is no need to repeat the urinalysis as a workup should be done.

A small amount of microscopic hematuria in an individual without symptoms (asymptomatic microscopic hematuria) can be found in many healthy individuals. It has been estimated that up to 10% of the population has asymptomatic microscopic hematuria. In brief, the older you are (generally over the age of 40), the more risk factors you have (smoking, occupational exposure), and the more red blood cells present, the more likely serious pathology (disease of the urinary tract including bladder cancer) will be found. If you have persistent microscopic hematuria without a known cause, a urologic assessment is recommended.

Our use of the term or terms Actos Lawyers is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Lawyers visit our site often.

http://www.seedol.com

Posted in Asbestos Lawyers Site | Tagged , |

Actos Recall News

Actos Recall: The bladder is the container in the body that stores urine. The other term for bladder is “vesical,” which is derived from the Latin word vesicular. The bladder is a soft, round structure that is located in the pelvis. The pubic bone is in front of the bladder; the rectum in men or the uterus in women is behind the bladder. Urine drains into the bladder through an opening on each side at the bottom of the bladder. Urine is stored in the bladder until a person is ready to urinate. In order to urinate, the muscle in the bladder wall squeezes, push­ing the urine out of the bladder through the urethra. In women, the urethra is short, only approximately 1 inch long. In men, it is much longer because it has to pass through the prostate and then the penis before finally opening at the tip of the penis.

In the middle of the abdomen, just beneath the lower ribs, are the kidneys. The kidneys filter the blood to produce urine. The urine that the kidneys produce exits the kidney through the renal pelvis and flows into the ureters. The ureters are soft, muscular tubes that are about the width of a pencil. They carry the urine from the kidneys down to the bladder, where they open into the base of the bladder.

For more information on Actos Recall follow us on our RSS Feeds.

While it’s not healthy to worry about every ache or pain you experience, knowing when your body feels different is a clue that you need to talk to your doctor. In addition, its important to fol­low a regular schedule of checkups—with your oncologist, primary care doctor, and even your dentist and eye doctor.Sometimes the journey from cancer back to wholeness and health can be slow. Your body, your rela­tionships, even your finances may change during the pro­cess. Be patient with yourself and those around you. Let yourself gradually come to the belief that, like Max, you are indeed a survivor.

In the context of bladder cancer, the word invasive describes whether cells from your bladder cancer have invaded the muscle wall of the bladder, and if so, how far into the layers of muscle tissue the cancer has penetrated. This can usually be determined from biopsy results, or occasionally when an operation has been performed to remove the bladder and some of the surrounding tissues. In some cases, organs near the bladder (such as the vagina in women, or the prostate in men) may have been invaded as well.

Information from other sources on Actos Recall

Invasive cancer extends farther into the body than super­ficial urothelial cancer and is, therefore, a more serious stage of the disease. It requires more complicated treatment, such as surgical removal of the bladder. This may, in turn, change how you manage basic physical functions in your every­day life, such as your bathroom habits and even your sex life. Also of importance is the significant rate of recurrence connected with invasive cancer. Often other organs, such as the lymph nodes, lung, or liver, are involved.

Our use of the term or terms Actos Recall is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Recall visit our site often.

http://www.seedol.com

Posted in Asbestos Lawyers Site | Tagged , |

Trans Vaginal Mesh Lawsuit Headlines

Trans Vaginal Mesh Lawsuit : There is considerable overlap of symptoms between women with DO and those with urodynamic stress incontinence (USI)10 such that symptomatology may not be relied upon to accurately diagnose either condition. In one study11 urgency and urge incontinence were found to have a sensitivity of 77.9% but a specificity of only 38.7% for DO. Approximately 34.9% of women complaining solely of USI were found to have DO. The likelihood of women having DO increases as the number of appropriate symptoms increases, with 89% probability of DO being diagnosed in the presence of all four major symptoms.

Medical and behavioural therapies for DO are often expensive and time-consuming. Accurate diagnosis helps aid uptake and compliance by ensuring that the right people are offered the right treatments. Frequency-volume charts give objective quantification of fluid intake, voiding frequency and functional bladder capacity. Urinary incontinence and episodes of urgency should also be documented. Typical features of DO are an increased diurnal urinary frequency associated with urgency and episodes of urge incontinence. Nocturia is one of the most salient features of DO.

For more information on Trans Vaginal Mesh Lawsuit follow us on our RSS Feeds.

Cranberry juice contains fructose, which could interfere with the adhesion of the fimbriae of uropathic bacteria to the bladder mucosa.11 A well-designed study has demonstrated a reduction in episodes of bacteruria and pyuria in a population of 153 elderly women (mean age 78.5 years) who drink 300 ml of either cranberry juice or a placebo drink, per day.12 Subjects randomized to the cranberry beverage had a risk of bacteruria (defined as organisms numbering a 105/ml) with pyuria that was only 42% of that in the control group (p=0.004).

heir chance of remaining bacteruric-pyuric, given that they were bacteruric-pyuric in the previous month, was only 27% of the chance in the control group (p=0.006). Both cranberry tablets and cranberry juice have also been shown to reduce the risk of UTI in sexually active women (aged 21-72) experiencing at least one symptomatic UTI per year (to 20% and 18% respectively) compared with placebo (to 32%) (p<0.05).13 Cost-effectiveness ratios revealed that cranberry tablets were twice as cost effective as organic cranberry juice.

Information from other sources on Trans Vaginal Mesh Lawsuit

Bearing in mind the potential for side-effects and the likelihood of resistant bacteria in patients receiving conventional antibiotic prophylaxis, the opportunity of giving a safe, naturally occurring substance, such as cranberry juice, deserves further consideration. Treatment should be aimed at relieving or removing the underlying cause of infection. Incomplete emptying should be investigated and treated to reduce or overcome outflow obstruction. This can be done surgically or by use of clean intermittent self-catheterization. Surgical repair of a cystocele may unkink the urethra and aid voiding; urethrotomy to a urethral stricture may overcome the limitation to flow.

Numerous conditions can affect the bladder without causing incontinence. Careful investigation is required to identify the underlying aetiology as the treatments are very different. Some conditions, such as a urinary tract infection (UTI) or poor habit, are easily rectified. Some of the other causes tend to run a chronic course and include a number of very disabling conditions.

Our use of the term or terms Trans Vaginal Mesh Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Trans Vaginal Mesh Lawsuit visit our site often.

http://www.seedol.com

Posted in Asbestos Lawyers Site | Tagged , |